参考文献/References:
[1]Liu K,Hua BT,Guo T,et al.The assessment of the long-term effects of elective CRT-D of coronary heart disease after PCI[J].Eur Rev Med Pharmacol Sci,2017,21(6):1313-1317.[2]金秀,李屏,曹宏玲.延续性护理对冠心病PCI术后患者氯吡格雷用药依从性及生活质量的影响[J].海南医学,2018,29(23):3402-3404.[3]虞彬,席建宏,周贤惠.延续护理干预对冠心病介入术后患者康复治疗的认知效果[J].新疆医科大学学报,2017,40(8):1118-1121,1124.[4]何翠竹,梁欣,苏斐,等.冠心病患者PCI术后延续护理的效果观察[J]. 河北医科大学学报,2016,37(8):893-896.[5]中华医学会心血管病学分会介入心脏病学组,中国医师协会心血管内科医师分会血栓防治专业委员会,中华心血管病杂志编辑委员会.中国经皮冠状动脉介入治疗指南(2016)[J].中华心血管病杂志,2016,44(5):382-400.[6]曹教育,陈霞,余华,等.延续性护理在冠心病经皮冠状动脉内介入术后患者的应用[J].安徽医药,2016,20(1):193-194. [7]刘梅讯,彭贵海,孔燕.延续护理对冠心病PCI术后康复患者的影响[J].海南医学,2016,27(16):2749-2752.[8]赖春燕,马建林.微信平台在冠心病PCI术后患者健康教育中的应用[J].中国数字医学,2019,14(4):76-78.[9]杨学青,张铮,李海香,等.移动医疗APP及微信群的延续护理在中老年冠心病患者中的应用[J].现代临床护理,2019,18(4):43-46.[10]王永琼,代昱虹,何跃敏.延续性护理对PCI术后冠心病患者依从性及不良事件的影响[J].实用临床医药杂志,2017,21(14):8-11.[11]耿晶,刘炜.基于微信的延续性护理对PCI术后患者复查依从性的影响[J].护理学杂志,2018,33(23):82-83.[12]李敏,朱玉峰,李虎,等.基于微信平台的随访和健康教育在冠心病患者介入治疗术后二级预防中的应用[J].华南国防医学杂志,2019,33(5):333-336,359.[13]阙静,杨巧芳.延续护理对老年冠心病PCI术后氯吡格雷用药依从性的影响[J].中华现代护理杂志,2018,24(15):1793-1796.[14]夏冬云,陈雁,王清,等.“互联网+护理服务”安全管理模式的实践[J].中国卫生质量管理,2021,28(2):50-53.[15]梁爱萍,赵禹.基于互联网平台下的延续性护理在冠心病PCI术后患者中的应用[J].检验医学与临床,2020,17(11):1614-1617.[16]冯琴,郑桂香,王娣,等.互联网+心脏康复延续性护理对冠心病经皮冠状动脉介入术后康复效果的研究[J].中国数字医学,2019,14(6):7-9.[17]江琳,孙青,张雅丽.基于微信平台的延续护理在冠心病介入术后患者中的应用[J].护理管理杂志,2017,17(2):140-142.[18]白璐,胡传来,韦学萍,等.延续性护理干预对提高冠心病介入术后患者自我管理水平的效果[J].安徽医学,2016,37(8):1037-1040.[19]杨志慧,李海滨,姜志安,等.延续护理对冠心病介入治疗患者出院后生活质量的影响[J].河北医药,2016,38(16):2537-2539.[20]马欣蕾,于水,马晶.基于“互联网+”的延续性护理在冠心病支架术后患者中的应用[J].中国护理管理,2018,18(9):1236-1240.[21]陈佳洁,徐菁,沈兰.互联网+下延续性护理干预对冠心病支架术后患者的护理效果研究[J].中国医学装备,2021,18(9):115-119.[22]宋晶,张金花,张爱华.冠心病病人PCI术后早期认知加工特征的质性研究[J].护理研究,2016,30(18):2248-2250.[23]吴丹妮,王兆霞,倪伟伟.冠心病PCI术后患者的信息化延续护理[J].护理学杂志,2018,33(1):15-17,24.[24]胡永琼,邓云霞.移动医疗App+微信群在冠心病PCI术后患者延续护理中的应用[J].中国护理管理,2016,16(3):394-397.
相似文献/References:
[1]袁 帅,邢晓博,李 晓,等.MTHFR基因多态性与中年男性冠状动脉病变程度的相关研究[J].医学信息,2018,31(03):67.[doi:10.3969/j.issn.1006-1959.2018.03.021]
YUAN Shuai,XING Xiao-bo,LI Xiao,et al.Association of MTHFR Gene Polymorphism with Coronary Artery Lesions in Middle-aged Men[J].Journal of Medical Information,2018,31(17):67.[doi:10.3969/j.issn.1006-1959.2018.03.021]
[2]张挺挺.经股和桡动脉介入治疗冠心病的临床疗效对比[J].医学信息,2018,31(03):114.[doi:10.3969/j.issn.1006-1959.2018.03.038]
ZHANG Ting-ting.Comparison of Clinical Effects of Interventional Treatment of Coronary Heart Disease by Femoral and Radial Artery[J].Journal of Medical Information,2018,31(17):114.[doi:10.3969/j.issn.1006-1959.2018.03.038]
[3]迮艳华.稳心颗粒联合美托洛尔治疗冠心病心律失常的疗效分析[J].医学信息,2018,31(03):139.[doi:10.3969/j.issn.1006-1959.2018.03.049]
ZE Yan-hua.Therapeutic Effect of Wenxin Granule Combined with Metoprolol on Arrhythmia of Coronary Heart Disease[J].Journal of Medical Information,2018,31(17):139.[doi:10.3969/j.issn.1006-1959.2018.03.049]
[4]张 旭.冠心病心绞痛患者进行护理干预的临床效果及
对护理质量影响研究[J].医学信息,2018,31(05):182.[doi:10.3969/j.issn.1006-1959.2018.05.068]
ZHANG Xu.Clinical Effect of Nursing Intervention in Patients with Angina Pectoris of Coronary Heart Disease and its Influence on Nursing Quality[J].Journal of Medical Information,2018,31(17):182.[doi:10.3969/j.issn.1006-1959.2018.05.068]
[5]向明明,赵晓辉.黑龙江省东部地区汉族人群冠心病的危险因素研究[J].医学信息,2018,31(07):122.[doi:10.3969/j.issn.1006-1959.2018.07.041]
XIANG Ming-ming,ZHAO Xiao-hui.Study on Risk Factors of Coronary Heart Disease in Han Nationality Population in Eastern Heilongjiang Province[J].Journal of Medical Information,2018,31(17):122.[doi:10.3969/j.issn.1006-1959.2018.07.041]
[6]王 坤,张永春.血清胆红素水平、单核细胞数、红细胞分布宽度与
冠状动脉病变程度的关系[J].医学信息,2018,31(08):53.[doi:10.3969/j.issn.1006-1959.2018.08.017]
WANG Kun,ZHANG Yong-chun.Relationship between Serum Bilirubin Level,Monocyte Count,Red Blood Cell Distribution Width and Severity of Coronary Artery Disease[J].Journal of Medical Information,2018,31(17):53.[doi:10.3969/j.issn.1006-1959.2018.08.017]
[7]毛红岩.冠状动脉介入治疗冠心病的疗效及
对患者血清炎症因子的影响[J].医学信息,2018,31(10):77.[doi:10.3969/j.issn.1006-1959.2018.10.023]
MAO Hong-yan.Effect of Coronary Intervention on Coronary Heart Disease and its Influence on Serum Inflammatory Factors[J].Journal of Medical Information,2018,31(17):77.[doi:10.3969/j.issn.1006-1959.2018.10.023]
[8]杨锦龙,刘 欢,吕秋菊,等.非糖尿病患者糖化血红蛋白和胰岛素抵抗与
冠状动脉病变程度的相关性研究[J].医学信息,2018,31(10):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
YANG Jin-long,LIU Huan,LV Qiu-ju,et al.Correlation between Glycosylated Hemoglobin and Insulin Resistance and Severity of Coronary Artery Disease in Non-diabetic Patients[J].Journal of Medical Information,2018,31(17):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
[9]李 铎,王建华.盐酸曲美他嗪片辅助治疗对冠心病伴心力衰竭患者氧化应激、心肌功能的影响[J].医学信息,2018,31(10):126.[doi:10.3969/j.issn.1006-1959.2018.10.041]
LI Duo,WANG Jian-hua.Effect of Trimetazidine Hydrochloride Tablets Adjuvant Therapy on Oxidative Stress and Myocardial Function in Patients with Coronary Heart Disease Complicated with Heart Failure[J].Journal of Medical Information,2018,31(17):126.[doi:10.3969/j.issn.1006-1959.2018.10.041]
[10]田跃雷.冠心病介入治疗后再狭窄的中西医防治[J].医学信息,2022,35(09):46.[doi:10.3969/j.issn.1006-1959.2022.09.011]
TIAN Yue-lei.Prevention and Treatment of Restenosis After Percutaneous Coronary Intervention with Chinese and Western Medicine[J].Journal of Medical Information,2022,35(17):46.[doi:10.3969/j.issn.1006-1959.2022.09.011]
[11]纪东华.卡托普利对冠心病介入治疗患者心室重构及炎性因子的影响[J].医学信息,2019,32(17):137.[doi:10.3969/j.issn.1006-1959.2019.17.045]
JI Dong-hua.Effects of Captopril on Ventricular Remodeling and Inflammatory Factors in Patients with
Coronary Heart Disease Undergoing Interventional Therapy[J].Journal of Medical Information,2019,32(17):137.[doi:10.3969/j.issn.1006-1959.2019.17.045]
[12]纪 翔.互联网联合心脏康复延续性护理对冠心病经皮冠状动脉介入术后康复效果的影响[J].医学信息,2022,35(10):186.[doi:10.3969/j.issn.1006-1959.2022.10.049]
JI Xiang.Effect of Internet Combined with Continuous Cardiac Rehabilitation Nursing on Rehabilitation of Coronary Heart Disease After Percutaneous Coronary Intervention[J].Journal of Medical Information,2022,35(17):186.[doi:10.3969/j.issn.1006-1959.2022.10.049]